Susquehanna International Group, LLP Spring Works Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$32.04 - $42.76 $41,652 - $55,588	1,300 Added 1.2%	109,200 $3.5 Million
Q2 2024 Aug 15, 2024	BUY	$36.06 - $47.62 $3.29 Million - $4.35 Million	91,300 Added 550.0%	107,900 $4.06 Million
Q1 2024 May 07, 2024	SELL	$36.5 - $52.5 $1.09 Million - $1.57 Million	-29,900 Reduced 64.3%	16,600 $817,000
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $698,886 - $1.37 Million	36,900 Added 384.38%	46,500 $1.7 Million
Q3 2023 Nov 14, 2023	SELL	$23.12 - $31.38 $520,200 - $706,050	-22,500 Reduced 70.09%	9,600 $221,000
Q2 2023 Aug 11, 2023	BUY	$23.15 - $32.71 $743,115 - $1.05 Million	32,100 New	32,100 $841,000
Q4 2022 Feb 14, 2023	BUY	$21.73 - $28.72 $97,785 - $129,240	4,500 Added 31.25%	18,900 $491,000
Q3 2022 Nov 14, 2022	BUY	$24.1 - $39.66 $347,040 - $571,104	14,400 New	14,400 $411,000

237

68.9M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.68B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.